Absci is creating better biologics for patients, faster, by unlocking novel biology with AI.
Absci is a biotechnology company that leverages generative AI and synthetic biology to design and develop novel biologics. Their integrated AI Drug Creation Platform combines wet lab experiments with AI models to accelerate drug discovery, optimize lead candidates, and uncover new therapeutic targets. By iteratively training AI models on experimental data, Absci can design differentiated antibodies and other biologics with improved properties. They partner with pharmaceutical companies and academic institutions to develop innovative therapies against challenging targets. Absci's approach aims to reduce the time and cost associated with traditional drug discovery, ultimately delivering life-changing medicines to patients more efficiently. Their AI-driven platform is applicable to a range of therapeutic areas, including oncology, immunology, and metabolic diseases.
Absci is a biotechnology company that leverages generative AI and synthetic biology to design and develop novel biologics.
Explore all tools that specialize in identify novel drug targets using ai and reverse immunology.. This domain focus ensures Absci delivers optimized results for this specific requirement.
Explore all tools that specialize in design de novo biologics with desired properties.. This domain focus ensures Absci delivers optimized results for this specific requirement.
Explore all tools that specialize in optimize lead candidates for efficacy, safety, and manufacturability.. This domain focus ensures Absci delivers optimized results for this specific requirement.
Explore all tools that specialize in generate experimental data to train and validate ai models.. This domain focus ensures Absci delivers optimized results for this specific requirement.
Explore all tools that specialize in develop cell lines for biologic production.. This domain focus ensures Absci delivers optimized results for this specific requirement.
Explore all tools that specialize in predict developability risks.. This domain focus ensures Absci delivers optimized results for this specific requirement.
Uses reverse immunology to identify antibodies from super immune responders, pairing them with novel targets ready for AI optimization.
Designs biologics from scratch using AI, optimizing for desired properties such as affinity, specificity, and stability.
Optimizes lead candidates across multiple parameters simultaneously, including efficacy, safety, and manufacturability.
Combines wet lab experiments with AI model training in iterative cycles, continuously improving the accuracy and predictive power of the models.
Predicts developability risks early in the drug discovery process, allowing for proactive mitigation strategies.
Contact Absci through their website (https://www.absci.com/) to express interest in a partnership.
Initial consultation with Absci's business development team to discuss project goals and requirements.
Collaborative target identification and program design.
Data integration and AI model training using Absci's platform.
Biologic design and in silico validation.
Wet lab experiments for data generation and model refinement.
Ongoing project management and data analysis support.
Regular progress updates and collaborative decision-making.
All Set
Ready to go
Verified feedback from other users.
"Absci is generally viewed as innovative and promising, leveraging AI to accelerate and improve the drug discovery process. They have established partnerships with major pharmaceutical companies, demonstrating industry confidence in their platform."
0Post questions, share tips, and help other users.
PostEra accelerates drug discovery using its AI platform, Proton, for medicinal chemistry.
Decoding biology to radically improve lives through AI-powered drug discovery.
A computational platform transforming therapeutics and materials discovery through physics-based modeling and AI.
Zipline offers workforce compliance screening solutions trusted by Australian Aged Care and Hospitals, ensuring compliant workers and visitors.
Nanox.AI solutions provide the ability to use AI to highlight and help identify patients with asymptomatic undetected chronic disease, initiating earlier diagnosis and preventative management.
ZAGENO is an online marketplace that streamlines the procurement of life science research supplies.
Youper is an AI-powered mental wellbeing app that provides personalized support through conversational techniques and mood tracking.
